News

On Tuesday 26 January, three scientists from The Genome Analysis Centre (TGAC) helped kick-off the first installment of ‘PubhD’ at the Cellar House in Eaton, Norwich.

Obesity can sometimes be shut down.

Startup develops more cost-effective test for assessing how cells respond to chemicals.

Looking at a brain tumor’s epigenetic signature may help guide therapy.

DNA damage can lead to gene inactivation or deregulation and cause various diseases such as cancer; however, many DNA repair mechanisms allow cells to survive against such damage.

Illumina, Inc. has announced that Dr. Frances Arnold has joined the company’s Board of Directors. Dr. Arnold manages a research group at the California Institute of Technology and is the Director of the Donna and Benjamin M. Rosen Bioengineering Center.

Venaxis®, Inc. has announced that it has entered into a series of agreements for a transaction with Strand Life Sciences Private Limited (Strand LS) and its shareholders.

Suspect gene may trigger runaway synaptic pruning during adolescence – NIH-funded study.

'To understand mental disorders, we must quantify the specific effect of each contributing gene mutation.' -- Dr. Sébastien Jacquemont, geneticist.

Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.